Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Association of HLA matching with outcome of UD-HSCT: EBMT study

Annalisa Ruggeri • 7 Dec 2019
ASH 2019
General Leukemia

Annalisa Ruggeri, MD, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, discusses a study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT). This study analyzed the association of donor-recipient HLA matching with the clinical outcomes of unrelated donor hematopoietic stem cell transplantation (UD-HSCT). Dr Ruggeri reveals data from the study reinforces the importance of HLA matching in the setting of UD-HSCT, as the best HLA match resulted in better overall and leukemia-free survival. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

More from Annalisa Ruggeri

Register for the hybrid EBMT-EHA 8th European CAR T-cell meeting: a message from the chair
1:48
Register for the hybrid EBMT-EHA 8th European CAR T-cell meeting: a message from the chair
Annalisa Ruggeri • 5 Feb 2026
EBMT 2020: cellular therapy day
4:55
EBMT 2020: cellular therapy day
Annalisa Ruggeri • 31 Aug 2020
Graft failure after unmanipulated haplo-HSCT with PT-Cy in AML
10:00
Graft failure after unmanipulated haplo-HSCT with PT-Cy in AML
Annalisa Ruggeri • 26 Aug 2020
HSCT with T-cell add-back of rivogenlecleucel in acute leukemia
3:39
HSCT with T-cell add-back of rivogenlecleucel in acute leukemia
Annalisa Ruggeri • 7 Dec 2019

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals